152 results on '"Schiappa, Renaud"'
Search Results
2. Post-therapeutic surveillance of HPV-driven oropharyngeal cancers: are we ready to change our practices?
3. Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort
4. Salvage brachytherapy for second ipsilateral breast tumor event: Relating dosimetric analysis to late side effects
5. Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database
6. Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
7. Impact of virtual surgical planning and three-dimensional modeling on time to surgery in mandibular reconstruction by free fibula flap
8. Information and oncosexological management in breast cancer patients
9. Second Conservative Treatment for Local Recurrence Breast Cancer: A GEC-ESTRO Oncological Outcome and Prognostic Factor Analysis
10. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial
11. Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group
12. Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer
13. 10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event
14. StatiCAL: an interactive tool for statistical analysis of biomedical data and scientific valorization
15. Failure of Initial Curative Treatment for Non-Metastatic Anal Squamous Cell Carcinoma: From Prognostic Factors Analysis to Stratified Treatment
16. Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
17. High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
18. Preoperative high-dose-rate brachytherapy for high-risk early-stage cervical cancer: Long-term clinical outcome analysis
19. Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer
20. Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non-Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging.
21. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes
22. TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer
23. Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study
24. Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation.
25. Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
26. Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
27. RUBY: Natural Language Processing of French Electronic Medical Records for Breast Cancer Research
28. The safety and efficacy of total mesorectal excision (TME) surgery following dose‐escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750)
29. #770 Preoperative brachytherapy of early-stage cervical cancer: results of the SFRO brachytherapy group multicenter cohort
30. 280: Salvage brachytherapy in second ipsilateral breast tumor event: Relating dosimetry with late toxicity
31. Safety and efficacy of two-drug combination in elderly patients with locally advanced non-small cell lung cancer and validation of the Charlson Index as a predictor of survival
32. Combining Stereotactic Radiotherapy and Conventional Radiotherapy for Peripheral Locally Advanced Lung Cancer
33. Validation of RUBY for Breast Cancer Knowledge Extraction From a Large French Electronic Medical Record System
34. Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study)
35. Breast Cancer and SARS-Cov2: Lessons from a Pandemic
36. Estimated survival outcomes and absolute chemotherapy treatment benefit using PREDICT Tool® and EndoPredict®, in hormone-positive early-stage breast cancer.
37. Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules
38. Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer
39. Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors
40. Added value of 18F-FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
41. Validation of the French version of the THYCA-QoL questionnaire for the health-related quality of life in thyroid cancer patients.
42. Additional file 1 of Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database
43. Validation and Improvement of a Convolutional Neural Network to Predict the Involved Pathology in a Head and Neck Surgery Cohort
44. Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.
45. Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell Carcinomas.
46. Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.
47. In Regard to Bondiau et al.
48. Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules.
49. Added value of 18F-FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
50. 413: CYBERNEO trial: Update of results at 14 years of follow-up.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.